Sun Pharmaceutical Industries Inc. is recalling 11,016 vials of Amphotericin B Liposome for Injection (50mg), a medication used to treat serious fungal infections. The recall was issued because testing showed the medication was "out of specification for assay," meaning the drug's potency or concentration may not be accurate. The affected medication was manufactured by Sun Pharmaceutical Medicare Limited in India and distributed across the United States.
If a medication's concentration is incorrect, patients may receive more or less of the drug than intended. This could lead to ineffective treatment of a serious infection or potential toxicity from a higher-than-expected dose.
Quantity: 11,016 vials. Manufactured by Sun Pharmaceutical Medicare Limited, Gujarat, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.